Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer

The gastrin-releasing peptide receptor (GRPR) is a promising molecular target for imaging and therapy of prostate cancer using bombesin peptides that bind to the receptor with high affinity. Targeted copper theranostics (TCTs) using copper radionuclides, (64)Cu for imaging and (67)Cu for therapy, of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, Truc T., van Dam, Ellen M., Sreekumar, Sreeja, Mpoy, Cedric, Blyth, Benjamin J., Muntz, Fenella, Harris, Matthew J., Rogers, Buck E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229378/
https://www.ncbi.nlm.nih.gov/pubmed/35745647
http://dx.doi.org/10.3390/ph15060728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229378/
https://www.ncbi.nlm.nih.gov/pubmed/35745647
http://dx.doi.org/10.3390/ph15060728

Ejemplares similares